EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Case Report: Obstetric and COVID-19-Related Morbidity and Mortality in Three Patients with Sickle Hemoglobinopathy

Shanea Gibson, Tiffany Hunter, Nadine Johnson

The American Journal of Tropical Medicine and Hygiene · 2024

DOI: 10.4269/ajtmh.23-0761 ↗

Kurz gefasst

Fallbericht in der Zeitschrift The American Journal of Tropical Medicine and Hygiene, 2024. Verfasst von Shanea Gibson und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynaecology, University Hospital of the West Indies, Kingston, Jamaica. Hauptthemen laut MEDLINE: COVID-19, Anemia, Sickle Cell, SARS-CoV-2, Pregnancy Complications, Infectious. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Approximately 3% of pregnant women have sickle cell disease (SCD). COVID-19, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), became a global pandemic in March 2020, resulting in more than 3,500 deaths in Jamaica by April 2023. Sickle cell disease is an immunocompromised state; therefore, contracting COVID-19 may result in adverse maternal/neonatal outcomes. Current literature focusing on individuals of Afro-Caribbean descent is limited. Our objective was to describe the obstetric and neonatal outcomes of pregnant patients with SCD who contracted COVID-19. A retrospective case series was conducted at the University Hospital of the West Indies (Jamaica) from 2020 to 2022. We describe the maternal and neonatal outcomes of three patients with COVID-19 and SCD (including two with hemoglobin SC disease and one with hemoglobin SS disease), with complications including the demise of a mother and a newborn. Vaso-occlusive crisis was the more common presentation. Two patients required ventilatory support. Although previous reports have shown similar clinical sequelae in pregnant and nonpregnant patients with SCD and COVID-19, maternal and neonatal deaths remain possible.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Anemia, Sickle CellSARS-CoV-2Pregnancy Complications, InfectiousHumansFemalePregnancyAdultInfant, NewbornPregnancy Complications, HematologicJamaicaRetrospective StudiesPregnancy Outcome

Autor:innen und Institutionen

  • Department of Obstetrics and Gynaecology, University Hospital of the West Indies, Kingston, Jamaica.
  • Department of Obstetrics and Gynaecology, University of the West Indies, Kingston, Jamaica.

Zitieren

APA

Gibson, S., Hunter, T., & Johnson, N. (2024). Case Report: Obstetric and COVID-19-Related Morbidity and Mortality in Three Patients with Sickle Hemoglobinopathy. The American Journal of Tropical Medicine and Hygiene. https://doi.org/10.4269/ajtmh.23-0761

Vancouver

Gibson S, Hunter T, Johnson N. Case Report: Obstetric and COVID-19-Related Morbidity and Mortality in Three Patients with Sickle Hemoglobinopathy. The American Journal of Tropical Medicine and Hygiene. 2024. doi:10.4269/ajtmh.23-0761

BibTeX
@article{Gibson2024,
  author = {Gibson, Shanea and Hunter, Tiffany and Johnson, Nadine},
  title = {Case Report: Obstetric and COVID-19-Related Morbidity and Mortality in Three Patients with Sickle Hemoglobinopathy},
  journal = {The American Journal of Tropical Medicine and Hygiene},
  year = {2024},
  doi = {10.4269/ajtmh.23-0761}
}
Kostenlos starten →